MedTrace Logo

The Role of Oxygen in the Management of Dyspnoea in Advanced Cancer

NCT00206609 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2005-09-21

No results posted yet for this study

Summary

The purpose of this study is to determine the effect that oxygen has when administered to patients complaining of shortness of breath, where the underlying cause of this symptom is advanced cancer. The study tests the hypothesis that oxygen improves shortness of breath more than air in this population. Both oxygen and air will be administered to patients in random order and in a blinded fashion, with patients asked to rate their shortness of breath before and after each gas. Finally patients will be asked which gas they prefer.

Conditions

Interventions

PROCEDURE

Oxygen and air administration

Sponsors & Collaborators

  • Peter MacCallum Cancer Centre, Australia

    collaborator OTHER

  • Bethlehem Griffiths Research Foundation

    collaborator OTHER

  • Australian and New Zealand Society of Palliative Medicine

    collaborator OTHER

  • Bayside Health

    lead OTHER_GOV

Principal Investigators

  • Jennifer AM Philip, MBBS · The Alfred

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2000-11-30
Completion
2005-03-31

Countries

  • Australia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00206609 on ClinicalTrials.gov